Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Objective: In this study, we aimed to obtain real-life data on the use of antimyeloma agents, which significantly increase overall survival (OS) in multiple myeloma (MM) patients, in primary plasma cell leukemia (pPCL) patients with poor prognosis. Materials and Methods: Data from 53 patients who w...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Ünal Ataş, Ozan Salim, Utku Iltar, Orhan Kemal Yücel, Ayşe Hilal Küçükdiler Eroğlu, Vedat Aslan, Murat Yıldırım, Özen Dedeoğlu, Sema Seçilmiş, Turgay Ulaş, Burak Deveci, Sedanur Karaman Gülsaran, Ayfer Gedük, Fatih Yaman, İbrahim Ethem Pınar, Senem Maral, Ahmet Sarıcı, Serhat Çelik, Hande Oğul, Sıdıka Gülkan Özkan, Aliihsan Gemici, Ahmet Kurşat Güneş, Anıl Tombak, İrfan Yavaşoğlu, Volkan Karakuş, Melda Cömert, Tayfur Toptaş, Mehmet Sinan Dal, Rabin Saba, Hakkı Onur Kırkızlar, Özgür Mehtap, Eren Gündüz, Fahir Özkalemkaş, Murat Albayrak, İlhami Berber, Muzaffer Keklik, Nil Güler, Hasan Atilla Özkan, Ömür Gökmen Sevindik, Zahit Bolaman, Erdal Kurtoğlu, Meltem Aylı, Tülin Fıratlı Tuğlular, Fevzi Altuntaş, Levent Ündar
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Turkish Society of Hematology 2024-12-01
Ráidu:	Turkish Journal of Hematology
Fáttát:	primary plasma cell leukemia antimyeloma agents proteasome inhibitors immunomodulatory agents hematopoietic stem cell transplantation
Liŋkkat:	https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-27448
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!